Discover the top 25 companies transforming the cancer biomarkers market, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Qiagen, and other industry leaders. Backed by a market projected to grow from US$24.5B to US$42.0B by 2029 at a CAGR of 11.3%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Cancer Biomarkers Companies

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is a global leader in the in vitro diagnostics (IVD) market, maintaining a dominant position through its Roche Diagnostics division. The company offers an extensive portfolio of integrated solutions, including molecular diagnostics, tissue diagnostics, and centralized laboratory testing, anchored by its renowned cobas series platforms. Roche’s strategic focus on personalized healthcare and rapid infectious disease testing is supported by continuous innovation, which enhances laboratory workflows and medical decision-making globally.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a premier global provider of analytical instruments, specialty diagnostics, and laboratory services. In the IVD sector, the company is recognized for its high-performance diagnostic reagents, molecular testing platforms, and laboratory automation systems designed to improve testing accuracy. Leveraging its industry-leading brands such as Applied Biosystems and Invitrogen, Thermo Fisher supports the evolving demands of precision medicine and genetic screening across clinical and research environments.

Qiagen

Qiagen is a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from biological samples. The company’s portfolio includes technologies for nucleic acid purification, PCR-based testing, and companion diagnostics, which are essential for molecular diagnostics and pharmaceutical development. Qiagen is particularly well-regarded for its innovations in automated testing workflows and its significant contribution to the fields of infectious disease and oncology research.

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a global manufacturer of medical diagnostic systems and life science research products, with a strong focus on clinical quality control. The company provides a wide range of specialized diagnostic tools for blood typing, immunohematology, and diabetes monitoring. Bio-Rad’s commitment to precision and reliability ensures that healthcare providers have access to high-quality instruments that maintain the integrity of clinical laboratory results worldwide.

Illumina, Inc.

Illumina, Inc. is a pioneer in genomics and a global leader in DNA sequencing and array-based technologies. The company serves customers in the clinical and research markets, providing integrated systems for large-scale genomic analysis used in cancer research, genetic disease testing, and reproductive health. Illumina’s innovation-driven strategy focuses on making genomic data more accessible and actionable, accelerating the transition of sequencing technology from the research lab to clinical diagnostics.

Agilent Technologies, Inc.

Agilent Technologies, Inc. provides high-performance analytical instruments, software, and services for a wide range of laboratory workflows, including the IVD market. The company specializes in pathology solutions, genomics testing tools, and companion diagnostics that support targeted therapies and precision medicine. Agilent’s focus on providing reliable data and high-quality reagents helps clinical laboratories improve diagnostic confidence and operational efficiency across the oncology and pharmaceutical care journeys.

Abbott Laboratories

Abbott Laboratories is a global healthcare leader with one of the most comprehensive diagnostics portfolios, spanning core laboratory, molecular, and point-of-care testing solutions. The company is highly regarded for its scalable Alinity and ARCHITECT platforms, as well as its market-leading rapid molecular systems. Abbott’s commitment to innovation and global reach ensures that healthcare providers have access to reliable, high-throughput tools to improve patient care and address emerging public health challenges.

Biomérieux

Biomérieux is a French multinational biotechnology company specializing in the development of diagnostic solutions for infectious diseases, cardiovascular conditions, and cancer. The company is a global leader in clinical microbiology, providing high-speed automated systems for pathogen identification and antibiotic susceptibility testing. Biomérieux’s focus on medical diagnostics and laboratory automation helps healthcare professionals make informed treatment decisions, ultimately improving patient outcomes and public health management.

Merck KGaA

Merck KGaA is a leading science and technology company that operates in the healthcare, life science, and electronics sectors. In the diagnostics market, the company provides a broad range of high-quality reagents, specialized kits, and analytical tools used in research and clinical laboratory settings. Merck’s commitment to innovation and collaborative research supports the development of new diagnostic methodologies and the advancement of life sciences research globally.

Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company that advances health by improving medical discovery, diagnostics, and the delivery of care. BD is a major provider of diagnostic tools, including specimen collection systems, microbiology analyzers, and flow cytometry platforms. The company’s focus on clinical laboratory efficiency and patient safety makes it a vital partner for hospitals and public health agencies, ensuring the reliable detection of diseases and pathogens.

Myriad Genetics, Inc.

Myriad Genetics, Inc. is a leading genetic testing and precision medicine company dedicated to providing insights that help patients and providers manage health through genetic data. The company offers a variety of molecular diagnostic tests for cancer risk, prenatal screening, and pharmacogenomics. Myriad’s emphasis on clinical validity and utility ensures that its genetic insights lead to more personalized and effective treatment plans for patients with complex medical conditions.

Sysmex Corporation

Sysmex Corporation is a Japanese healthcare company and a global leader in hematology diagnostics, holding a dominant market share in blood cell analysis and laboratory automation. The company provides advanced diagnostic systems and reagents for hematology, urinalysis, and immunochemistry. Sysmex’s focus on technological innovation and high-quality testing helps clinical laboratories around the world deliver accurate results for the early detection and monitoring of blood-related health conditions.

Hologic, Inc.

Hologic, Inc. is a medical technology company focused on improving women’s health through early detection and treatment. The company is a global leader in molecular diagnostics, particularly through its Panther system and Aptima assays used for infectious disease and cervical cancer screening. Hologic’s commitment to clinical excellence and innovative diagnostic tools empowers healthcare providers to deliver superior care and improve health outcomes for women worldwide.

Quest Diagnostics

Quest Diagnostics is the world’s leading provider of diagnostic information services, offering a vast menu of routine blood work, advanced molecular diagnostics, and pathology services. The company operates a large network of full-service laboratories and patient service centers, providing critical insights that inform clinical decisions and improve patient care. Quest’s focus on data-driven health management and operational efficiency makes it a primary partner for healthcare providers and patients across the United States.

Centogene N.V.

Centogene N.V. is a specialized healthcare company focused on rare diseases, utilizing its extensive genetic database and clinical data to provide advanced diagnostic insights. The company offers a comprehensive range of genetic testing services and multi-omic analysis to support early diagnosis and treatment monitoring for orphan diseases. Centogene’s commitment to data-driven medicine and clinical research accelerates the development of personalized therapies and improves the quality of life for patients with rare conditions.

Biogenex

Biogenex is a global provider of molecular pathology solutions, specializing in automated systems and reagents for tissue-based cancer diagnostics. The company offers a range of high-performance tools for immunohistochemistry (IHC) and in situ hybridization (ISH), which are essential for identifying specific biomarkers in tissue samples. Biogenex’s focus on innovation in pathology automation helps clinicians achieve more accurate and consistent diagnostic results, supporting the delivery of personalized oncology care.

Siemens Healthineers

Siemens Healthineers is a major global medical technology company that provides a broad spectrum of diagnostic imaging, laboratory diagnostics, and advanced healthcare IT solutions. The company is a market leader in high-performance laboratory automation and point-of-care testing, offering scalable systems that improve laboratory workflows and diagnostic precision. Siemens’ commitment to digital health and AI-enabled tools helps healthcare organizations deliver personalized care and improve patient outcomes across various clinical specialties.

Exact Sciences

Exact Sciences is a prominent molecular diagnostics company focused on the early detection and prevention of cancer. The company is best known for its Cologuard test, a non-invasive stool-based DNA screening option for colorectal cancer. Exact Sciences’ innovation-driven strategy emphasizes the development of highly accurate and patient-friendly diagnostic tools that aim to catch cancer at its earliest, most treatable stages, ultimately reducing cancer-related mortality.

R&D Systems, Inc.

R&D Systems, Inc., a Bio-Techne brand, is a leading provider of high-quality proteins, antibodies, and immunoassay kits used in life science research and clinical diagnostics. The company offers an extensive portfolio of tools for studying cell signaling, immunology, and oncology. R&D Systems’ commitment to product quality and scientific rigor ensures that researchers and clinicians have access to reliable reagents that facilitate the discovery of new biomarkers and the development of innovative diagnostic tests.

Biovision Inc.

Biovision Inc., a part of Abcam, is a specialized life science company that develops and manufactures a wide range of assays, reagents, and kits for biochemistry and cell biology research. The company provides high-performance tools for studying metabolic pathways, cell death, and protein quantification. Biovision’s focus on cost-effective and user-friendly products supports the advancement of biomedical research and the development of early-stage diagnostic applications in clinical and academic laboratories.

Olink

Olink, now part of Thermo Fisher Scientific, is a high-tech life science company specializing in advanced protein analysis and high-throughput proteomics. The company’s Proximity Extension Assay (PEA) technology allows for the simultaneous measurement of thousands of proteins from small biological samples with high specificity and sensitivity. Olink’s focus on providing deep insights into human biology and disease mechanisms supports the discovery of novel biomarkers and the development of precision medicine solutions.

Asuragen, Inc.

Asuragen, Inc., a Bio-Techne company, is a molecular diagnostics manufacturer specializing in the development of innovative kits and assays for genetic diseases and oncology. The company is recognized for its expertise in challenging genomic targets, providing reliable solutions for fragile X syndrome testing and oncology biomarker detection. Asuragen’s commitment to scientific excellence and simplified testing workflows ensures that clinical laboratories can deliver accurate diagnostic results for complex genetic conditions.

Meso Scale Diagnostics, LLC

Meso Scale Diagnostics, LLC (MSD) is a global leader in high-performance electrochemiluminescence (ECL) assays and instrumentation used in life science research and clinical diagnostics. The company’s platform allows for the sensitive and multiplexed detection of biomarkers in complex biological samples. MSD’s focus on providing reliable, high-throughput tools for pharmaceutical research and clinical trials makes it a critical partner for organizations involved in drug discovery and personalized medicine development.

Invivoscribe, Inc.

Invivoscribe, Inc. is a global provider of standardized molecular diagnostic products and services for oncology and personalized medicine. The company specializes in PCR-based assays and next-generation sequencing (NGS) tools for the detection of hematologic malignancies and the monitoring of minimal residual disease (MRD). Invivoscribe’s commitment to quality and clinical validation helps healthcare providers deliver accurate and timely diagnostic information, guiding the management of patients with blood-related cancers.

Inoviq Ltd.

Inoviq Ltd. is an emerging biotechnology company focused on the development and commercialization of innovative diagnostic and exosome-based solutions for cancer and other diseases. The company offers tools for exosome isolation and the detection of cancer biomarkers, aiming to improve early disease detection and treatment monitoring. Inoviq’s focus on next-generation diagnostic technologies supports the advancement of precision medicine and the development of non-invasive screening options for oncology patients.

Download PDF Brochure:“Click Here”